These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 32338339)

  • 1. Upregulated cyclins may be novel genes for triple-negative breast cancer based on bioinformatic analysis.
    Lu Y; Yang G; Xiao Y; Zhang T; Su F; Chang R; Ling X; Bai Y
    Breast Cancer; 2020 Sep; 27(5):903-911. PubMed ID: 32338339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer.
    Qiu P; Guo Q; Yao Q; Chen J; Lin J
    PLoS One; 2021; 16(11):e0254283. PubMed ID: 34797837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDK1 and CCNB1 as potential diagnostic markers of rhabdomyosarcoma: validation following bioinformatics analysis.
    Li Q; Zhang L; Jiang J; Zhang Y; Wang X; Zhang Q; Wang Y; Liu C; Li F
    BMC Med Genomics; 2019 Dec; 12(1):198. PubMed ID: 31870357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and prognostic value of
    Xing Z; Wang X; Liu J; Zhang M; Feng K; Wang X
    J Int Med Res; 2021 Apr; 49(4):300060520980647. PubMed ID: 33896262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatical Analysis of Gene Expression Omnibus Database Associates TAF7/CCNB1, TAF7/CCNA2, and GTF2E2/CDC20 Pathways with Glioblastoma Development and Prognosis.
    Yang L; Zeng W; Sun H; Huang F; Yang C; Cai X; Lu Y; Zeng J; Yang K
    World Neurosurg; 2020 Jun; 138():e492-e514. PubMed ID: 32147549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers.
    Liu Y; Teng L; Fu S; Wang G; Li Z; Ding C; Wang H; Bi L
    BMC Cancer; 2021 May; 21(1):644. PubMed ID: 34053447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CDK1, CCNB1 and NDC80 are associated with prognosis and progression of hepatitis B virus-associated hepatocellular carcinoma: a bioinformatic analysis].
    Li Y; Wu D; Wei C; Yang X; Zhou S
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1509-1518. PubMed ID: 34755666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDK1 and CCNA2 play important roles in oral squamous cell carcinoma.
    Zhang J; Di Y; Zhang B; Li T; Li D; Zhang H
    Medicine (Baltimore); 2024 Apr; 103(16):e37831. PubMed ID: 38640322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
    Zhai Q; Li H; Sun L; Yuan Y; Wang X
    Breast Cancer; 2019 Nov; 26(6):784-791. PubMed ID: 31197620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of key molecular markers in epithelial ovarian cancer by integrated bioinformatics analysis.
    Qin W; Yuan Q; Liu Y; Zeng Y; Ke D; Dai X; Shuai Y; Hu J; Shi H
    Taiwan J Obstet Gynecol; 2021 Nov; 60(6):983-994. PubMed ID: 34794761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in tumor tissues predicts poor survival in pancreatic ductal adenocarcinoma.
    Dong S; Huang F; Zhang H; Chen Q
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30765611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis.
    Deng JL; Xu YH; Wang G
    Front Genet; 2019; 10():695. PubMed ID: 31428132
    [No Abstract]   [Full Text] [Related]  

  • 13. KEGG-expressed genes and pathways in triple negative breast cancer: Protocol for a systematic review and data mining.
    Chen J; Liu C; Cen J; Liang T; Xue J; Zeng H; Zhang Z; Xu G; Yu C; Lu Z; Wang Z; Jiang J; Zhan X; Zeng J
    Medicine (Baltimore); 2020 May; 99(18):e19986. PubMed ID: 32358373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis.
    Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L
    Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential oncogenes in triple-negative breast cancer based on bioinformatics analyses.
    Xiao X; Zhang Z; Luo R; Peng R; Sun Y; Wang J; Chen X
    Oncol Lett; 2021 May; 21(5):363. PubMed ID: 33747220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of CXCR4 and CXCL10 as Potential Predictive Biomarkers in Triple Negative Breast Cancer (TNBC).
    Chuan T; Li T; Yi C
    Med Sci Monit; 2020 Jan; 26():e918281. PubMed ID: 31924747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of hub genes in triple-negative breast cancer by integrated bioinformatics analysis.
    Wei LM; Li XY; Wang ZM; Wang YK; Yao G; Fan JH; Wang XS
    Gland Surg; 2021 Feb; 10(2):799-806. PubMed ID: 33708561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Hub genes with prognostic values in colorectal cancer by integrated bioinformatics analysis.
    Li S; Li T; Shi YQ; Xu BJ; Deng YY; Sun XG
    Cancer Biomark; 2024; 40(1):27-45. PubMed ID: 38393891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel biomarkers identified in triple-negative breast cancer through RNA-sequencing.
    Chen YL; Wang K; Xie F; Zhuo ZL; Liu C; Yang Y; Wang S; Zhao XT
    Clin Chim Acta; 2022 Jun; 531():302-308. PubMed ID: 35504321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.